Multi-institutional Analysis of 200 COVID-19 Patients Treated With Extracorporeal Membrane Oxygenation: Outcomes and Trends
MD Jeffrey P Jacobs, MSA, CCP (Emeritus Alfred H Stammers, MD James D St Louis, J W Awori Hayanga, MD Michael S Firstenberg, CCP (Emeritus Linda B Mongero, PhD Eric A Tesdahl, MD Keshava Rajagopal, PhD Faisal H Cheema, MD Kirti Patel, CCP Tom Coley, CCP Anthony K Sestokas, PhD Marvin J Slepian, MD Vinay Badhwar
The Annals of Thoracic Surgery, doi:10.1016/j.athoracsur.2021.06.026
BACKGROUND The role of extracorporeal membrane oxygenation (ECMO) in the management of patients with COVID-19 continues to evolve. The purpose of this analysis is to review our multi-institutional clinical experience involving 200 consecutive patients at 29 hospitals with confirmed COVID-19 supported with ECMO. METHODS This analysis includes our first 200 COVID-19 patients with complete data who were supported with and separated from ECMO. These patients were cannulated between March 17 and December 1, 2020. Differences by mortality group were assessed using c 2 tests for categoric variables and Kruskal-Wallis rank sum tests and Welch's analysis of variance for continuous variables.
RESULTS Median ECMO time was 15 days (interquartile range, 9 to 28). All 200 patients have separated from ECMO: 90 patients (45%) survived and 110 patients (55%) died. Survival with venovenous ECMO was 87 of 188 patients (46.3%), whereas survival with venoarterial ECMO was 3 of 12 patients (25%). Of 90 survivors, 77 have been discharged from the hospital and 13 remain hospitalized at the ECMO-providing hospital. Survivors had lower median age (47 versus 56 years, P < .001) and shorter median time from diagnosis to ECMO cannulation (8 versus 12 days, P [ .003). For the 90 survivors, adjunctive therapies on ECMO included intravenous steroids (64), remdesivir (49), convalescent plasma (43), anti-interleukin-6 receptor blockers (39), prostaglandin (33), and hydroxychloroquine (22). CONCLUSIONS Extracorporeal membrane oxygenation facilitates survival of select critically ill patients with COVID-19. Survivors tend to be younger and have a shorter duration from diagnosis to cannulation. Substantial variation exists in drug treatment of COVID-19, but ECMO offers a reasonable rescue strategy.
References
Barbaro, Maclaren, Boonstra, Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry, Lancet
Bartlett, Ogino, Brodie, Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure, ASAIO J
Clerkin, Fried, Raikhelkar, COVID-19 and cardiovascular disease, Circulation
Henry, COVID-19, ECMO, and lymphopenia: a word of caution, Lancet Respir Med
Jacobs, Falasa, Machuca, Extracorporeal membrane oxygenation for patients with refractory COVID-19: what do we know and what do we need to learn?
Jacobs, Stammers, Louis, Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise 8 JACOBS ET AL ECMO AND COVID-19
Kon, Smith, Chang, Extracorporeal membrane oxygenation support in severe COVID-19, Ann Thorac Surg
Madjid, Safavi-Naeini, Solomon, Vardeny, Potential effects of coronaviruses on the cardiovascular system: a review, JAMA Cardiol
Rajagopal, Keller, Akhanti, Advanced pulmonary and cardiac support of COVID-19 patients: emerging recommendations from ASAIO-a "living working document, ASAIO J
Shih, Dimaio, Squiers, Venovenous extracorporeal membrane oxygenation for patients with refractory COVID-19: multicenter experience of referral hospitals in a large health care system
Yang, Yu, Xu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med
DOI record:
{
"DOI": "10.1016/j.athoracsur.2021.06.026",
"ISSN": [
"0003-4975"
],
"URL": "http://dx.doi.org/10.1016/j.athoracsur.2021.06.026",
"alternative-id": [
"S0003497521011772"
],
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Multi-institutional Analysis of 200 COVID-19 Patients Treated With Extracorporeal Membrane Oxygenation: Outcomes and Trends"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "The Annals of Thoracic Surgery"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.athoracsur.2021.06.026"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2022 by The Society of Thoracic Surgeons"
}
],
"author": [
{
"affiliation": [],
"family": "Jacobs",
"given": "Jeffrey P.",
"sequence": "first"
},
{
"affiliation": [],
"family": "Stammers",
"given": "Alfred H.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "St Louis",
"given": "James D.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Hayanga",
"given": "J. W. Awori",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Firstenberg",
"given": "Michael S.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mongero",
"given": "Linda B.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tesdahl",
"given": "Eric A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Rajagopal",
"given": "Keshava",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Cheema",
"given": "Faisal H.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Patel",
"given": "Kirti",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Coley",
"given": "Tom",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Sestokas",
"given": "Anthony K.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Slepian",
"given": "Marvin J.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Badhwar",
"given": "Vinay",
"sequence": "additional"
}
],
"container-title": "The Annals of Thoracic Surgery",
"container-title-short": "The Annals of Thoracic Surgery",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"clinicalkey.fr",
"clinicalkey.jp",
"clinicalkey.com.au",
"clinicalkey.es",
"clinicalkey.com",
"annalsthoracicsurgery.org",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2021,
7,
6
]
],
"date-time": "2021-07-06T14:48:38Z",
"timestamp": 1625582918000
},
"deposited": {
"date-parts": [
[
2022,
4,
19
]
],
"date-time": "2022-04-19T18:04:46Z",
"timestamp": 1650391486000
},
"indexed": {
"date-parts": [
[
2023,
10,
20
]
],
"date-time": "2023-10-20T04:46:49Z",
"timestamp": 1697777209114
},
"is-referenced-by-count": 10,
"issue": "5",
"issued": {
"date-parts": [
[
2022,
5
]
]
},
"journal-issue": {
"issue": "5",
"published-print": {
"date-parts": [
[
2022,
5
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
5,
1
]
],
"date-time": "2022-05-01T00:00:00Z",
"timestamp": 1651363200000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0003497521011772?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0003497521011772?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "1452-1460",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2022,
5
]
]
},
"published-print": {
"date-parts": [
[
2022,
5
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1161/CIRCULATIONAHA.120.046941",
"article-title": "COVID-19 and cardiovascular disease",
"author": "Clerkin",
"doi-asserted-by": "crossref",
"first-page": "1648",
"journal-title": "Circulation",
"key": "10.1016/j.athoracsur.2021.06.026_bib2",
"volume": "141",
"year": "2019"
},
{
"DOI": "10.1001/jamacardio.2020.1286",
"article-title": "Potential effects of coronaviruses on the cardiovascular system: a review",
"author": "Madjid",
"doi-asserted-by": "crossref",
"first-page": "831",
"journal-title": "JAMA Cardiol",
"key": "10.1016/j.athoracsur.2021.06.026_bib3",
"volume": "5",
"year": "2020"
},
{
"DOI": "10.1097/MAT.0000000000001185",
"article-title": "Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in coronavirus disease 2019: experience with 32 patients",
"author": "Jacobs",
"doi-asserted-by": "crossref",
"first-page": "722",
"journal-title": "ASAIO J",
"key": "10.1016/j.athoracsur.2021.06.026_bib4",
"volume": "66",
"year": "2020"
},
{
"DOI": "10.1016/S2213-2600(20)30079-5",
"article-title": "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study",
"author": "Yang",
"doi-asserted-by": "crossref",
"first-page": "475",
"journal-title": "Lancet Respir Med",
"key": "10.1016/j.athoracsur.2021.06.026_bib5",
"volume": "8",
"year": "2020"
},
{
"DOI": "10.1016/S2213-2600(20)30119-3",
"article-title": "COVID-19, ECMO, and lymphopenia: a word of caution",
"author": "Henry",
"doi-asserted-by": "crossref",
"first-page": "e24",
"journal-title": "Lancet Respir Med",
"key": "10.1016/j.athoracsur.2021.06.026_bib6",
"volume": "8",
"year": "2020"
},
{
"DOI": "10.1016/j.athoracsur.2020.07.002",
"article-title": "Extracorporeal membrane oxygenation support in severe COVID-19",
"author": "Kon",
"doi-asserted-by": "crossref",
"first-page": "537",
"journal-title": "Ann Thorac Surg",
"key": "10.1016/j.athoracsur.2021.06.026_bib7",
"volume": "111",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(20)32008-0",
"article-title": "Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry",
"author": "Barbaro",
"doi-asserted-by": "crossref",
"first-page": "1071",
"journal-title": "Lancet",
"key": "10.1016/j.athoracsur.2021.06.026_bib8",
"volume": "396",
"year": "2020"
},
{
"DOI": "10.1097/MAT.0000000000001173",
"article-title": "Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure",
"author": "Bartlett",
"doi-asserted-by": "crossref",
"first-page": "472",
"journal-title": "ASAIO J",
"key": "10.1016/j.athoracsur.2021.06.026_bib11",
"volume": "66",
"year": "2020"
},
{
"DOI": "10.1097/MAT.0000000000001180",
"article-title": "Advanced pulmonary and cardiac support of COVID-19 patients: emerging recommendations from ASAIO—a “living working document",
"author": "Rajagopal",
"doi-asserted-by": "crossref",
"first-page": "588",
"journal-title": "ASAIO J",
"key": "10.1016/j.athoracsur.2021.06.026_bib12",
"volume": "66",
"year": "2020"
},
{
"DOI": "10.1016/j.jtcvs.2020.11.073",
"article-title": "Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): multicenter experience of referral hospitals in a large health care system",
"author": "Shih",
"doi-asserted-by": "crossref",
"first-page": "1071",
"journal-title": "J Thorac Cardiovasc Surg",
"key": "10.1016/j.athoracsur.2021.06.026_bib13",
"volume": "163",
"year": "2022"
},
{
"DOI": "10.1016/j.jtcvs.2020.11.128",
"article-title": "Commentary: extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): what do we know and what do we need to learn?",
"author": "Jacobs",
"doi-asserted-by": "crossref",
"first-page": "1080",
"journal-title": "J Thorac Cardiovasc Surg",
"key": "10.1016/j.athoracsur.2021.06.026_bib14",
"volume": "163",
"year": "2022"
}
],
"reference-count": 11,
"references-count": 11,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0003497521011772"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Cardiology and Cardiovascular Medicine",
"Pulmonary and Respiratory Medicine",
"Surgery"
],
"subtitle": [],
"title": "Multi-institutional Analysis of 200 COVID-19 Patients Treated With Extracorporeal Membrane Oxygenation: Outcomes and Trends",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "113"
}
